Table 2.

Clinical restaging post NACT and histomorphological evaluation

		Case ( n )	%
Response to NACT (radiographic restaging)
	CR	3	7.9
	PR	24	63.2
	SD	6	15.8
	PD	5	13.2
Histomorphological evaluation
	No vital residual tumor cells	2	5.3
	Decreased vital residual tumor cells with fibrosis	9	23.7
	No vital post chemotherapy change	14	36.8
	Metastasis post NACT	1	2.6